These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 27080302)
1. MiR-502/SET8 regulatory circuit in pathobiology of breast cancer. Liu B; Zhang X; Song F; Zheng H; Zhao Y; Li H; Zhang L; Yang M; Zhang W; Chen K Cancer Lett; 2016 Jul; 376(2):259-67. PubMed ID: 27080302 [TBL] [Abstract][Full Text] [Related]
2. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539 [TBL] [Abstract][Full Text] [Related]
3. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Song F; Zheng H; Liu B; Wei S; Dai H; Zhang L; Calin GA; Hao X; Wei Q; Zhang W; Chen K Clin Cancer Res; 2009 Oct; 15(19):6292-300. PubMed ID: 19789321 [TBL] [Abstract][Full Text] [Related]
4. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464 [TBL] [Abstract][Full Text] [Related]
5. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3. Chen SY; Teng SC; Cheng TH; Wu KJ Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells. Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931 [TBL] [Abstract][Full Text] [Related]
7. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2. Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L Cell Death Dis; 2019 Feb; 10(3):176. PubMed ID: 30792382 [TBL] [Abstract][Full Text] [Related]
8. microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8. Yu N; Huangyang P; Yang X; Han X; Yan R; Jia H; Shang Y; Sun L J Biol Chem; 2013 Jul; 288(27):19633-42. PubMed ID: 23720754 [TBL] [Abstract][Full Text] [Related]
9. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4. Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397 [TBL] [Abstract][Full Text] [Related]
10. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression. Xia H; Long J; Zhang R; Yang X; Ma Z Biomed Pharmacother; 2015 Oct; 75():105-10. PubMed ID: 26276160 [TBL] [Abstract][Full Text] [Related]
11. A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome. Guo Z; Wu C; Wang X; Wang C; Zhang R; Shan B Int J Cancer; 2012 Sep; 131(6):1318-22. PubMed ID: 22095217 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer. Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659 [TBL] [Abstract][Full Text] [Related]
13. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway. Wu H; Li J; Guo E; Luo S; Wang G Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800 [TBL] [Abstract][Full Text] [Related]
14. SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities. Yang F; Sun L; Li Q; Han X; Lei L; Zhang H; Shang Y EMBO J; 2012 Jan; 31(1):110-23. PubMed ID: 21983900 [TBL] [Abstract][Full Text] [Related]
15. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition. Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858 [TBL] [Abstract][Full Text] [Related]
16. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein. Lin L; Liu D; Liang H; Xue L; Su C; Liu M Int J Clin Exp Pathol; 2015; 8(6):6646-55. PubMed ID: 26261546 [TBL] [Abstract][Full Text] [Related]
17. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer. Li W; Zhai L; Zhao C; Lv S Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773 [TBL] [Abstract][Full Text] [Related]
18. [SNP rs16917496 within SET8 3'UTR is associated with the age of onset of breast cancer]. Zhang BL; Song FJ; Zheng H; Zhang LN; Zhao YR; Chen KX Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):835-7. PubMed ID: 23291132 [TBL] [Abstract][Full Text] [Related]
19. Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer. Wang J; Zhang X; Shi J; Cao P; Wan M; Zhang Q; Wang Y; Kridel SJ; Liu W; Xu J; Zhang Q; Sui G Oncotarget; 2016 Nov; 7(48):78566-78576. PubMed ID: 27713175 [TBL] [Abstract][Full Text] [Related]
20. microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7. Liu J; Zhou Y; Shi Z; Hu Y; Meng T; Zhang X; Zhang S; Zhang J DNA Cell Biol; 2016 Sep; 35(9):521-9. PubMed ID: 27303812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]